Australian Public Assessment Reports for prescription medicines (AusPARs) users have been invited to participate in a survey conducted by Therapeutic Good Administrations (TGA). The TGA wants to know what the users think about the AusPARs for prescription medicines.
Survey responses may be lodged without specific identifiers, i.e. email address and organisational affiliation are optional. The link to the survey is now live and will be open to 31 July 2016:
AusPARs for newly evaluated prescription medicines are regularly published online and may be viewed here:
AusPARs provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application. The TGA evaluates the safety, quality and effectiveness of all prescription medicines that submitted by companies who plan to make the products available in Australia or to change something about the medicine once it is available.
As of July 2013, the format of AusPARs was updated to give a clearer focus on the outcomes of the TGA’s evaluation process and the rationale on which a decision to accept or reject an application is made. The information in the body of the AusPAR now includes only the clinical evaluator’s summaries of pharmacokinetics, pharmacodynamics, efficacy and safety, as well as the first and second round benefit-risk assessments.
For further information about AusPARs or the TGA’s survey, please email: email@example.com
More articles on My Health Career:
- 61 recommendations for Choosing Wisely Australia: The Next Wave campaign
- Cannabis products made legal for Australian patients
- The Pharmacy Guild of Australia’s position statement on substitution of biosimilar medicines
Image: ArtsyBee – pixabay